As used in this report, each of the terms "we," "us," "our," the "Company" and
"Simulations Plus" refers to Simulations Plus, Inc. and Cognigen Corporation,
unless otherwise stated or the context otherwise requires.
Simulations Plus, Inc., incorporated in 1996, is a premier developer of
groundbreaking drug discovery and development software for mechanistic modeling
and simulation. Our software is licensed to major pharmaceutical, biotechnology,
agrochemical, and food industry companies and to regulatory agencies worldwide
for use in the conduct of industry-based research. We also provide consulting
services to these industries. Recently, we have been exploring the application
of some of our machine-learning technologies for problems in aerospace and
healthcare outside of our traditional markets. Simulations Plus is headquartered
in Southern California and its common stock trades on the NASDAQ Capital Market
under the symbol "SLP.